BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3128347)

  • 1. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator.
    Dzik WH; Arkin CF; Jenkins RL; Stump DC
    Blood; 1988 Apr; 71(4):1090-5. PubMed ID: 3128347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation.
    Porte RJ; Bontempo FA; Knot EA; Lewis JH; Kang YG; Starzl TE
    Transplantation; 1989 Jun; 47(6):978-84. PubMed ID: 2499962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
    Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibrinolysis in orthotopic but not in heterotopic liver transplantation: the role of the anhepatic phase.
    Bakker CM; Metselaar HJ; Groenland TN; Terpstra OT; Stibbe J
    Transpl Int; 1992; 5 Suppl 1():S173-4. PubMed ID: 14621767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period.
    Bakker CM; Metselaar HJ; Groenland TN; Gomes MJ; Knot EA; Hesselink EJ; Schalm SW; Stibbe J; Terpstra OT
    Hepatology; 1992 Aug; 16(2):404-8. PubMed ID: 1639350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
    Ray MJ; Marsh NA; Hawson GA
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig.
    Bakker CM; Blankensteijn JD; Schlejen P; Porte RJ; Gomes MJ; Lampe HI; Stibbe J; Terpstra OT
    HPB Surg; 1994; 7(4):265-80. PubMed ID: 8204546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative evolution of coagulation parameters and t-PA/PAI balance in orthotopic liver transplantation.
    Arnoux D; Boutière B; Houvenaeghel M; Rousset-Rouvière A; Le Treut P; Sampol J
    Thromb Res; 1989 Aug; 55(3):319-28. PubMed ID: 2506668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
    Crookston KP; Marsh CL; Chandler WL
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary fibrinolysis during supraceliac aortic clamping.
    Illig KA; Green RM; Ouriel K; Riggs PN; Bartos S; Whorf R; DeWeese JA; Chhibber A; Marder VJ; Francis CW
    J Vasc Surg; 1997 Feb; 25(2):244-51; discussion 252-4. PubMed ID: 9052559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction.
    Stangl K; Laule M; Tenckhoff B; Stangl V; Gliech V; Dübel P; Grohmann A; Melzer C; Langel J; Wernecke KD; Baumann G; Ziemer S
    Am J Cardiol; 1998 Apr; 81(7):841-7. PubMed ID: 9555772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.
    Moore HB; D'Alessandro A; Moore EE; Wither M; Lawson PJ; Huebner BR; Hansen K; Choudhury R; Nydam TL
    Blood Transfus; 2019 Jul; 17(4):312-320. PubMed ID: 30747704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tissue-type plasminogen activator antigen release is not accompanied by increased systemic fibrinolytic activity in severe neonatal respiratory distress syndrome.
    Brus F; Oetomo SB; Schieving J; Groothuis E; Okken A; van Oeveren W
    Pediatr Res; 1999 Apr; 45(4 Pt 1):588-94. PubMed ID: 10203153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
    Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Blumhardt G; Kluft C; Riess H
    Semin Thromb Hemost; 1993; 19(3):311-4. PubMed ID: 7689759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.